EKF Diagnostics at Medlab Middle East 2018

04/12/2017

EKF Diagnostics will exhibit at MEDLAB Middle East 2018, showcasing our latest data management solutions for the DiaSpect Tm hemoglobin analyzer and Quo-Test® HbA1c analyzer. Diabetes is a growing health concern in the Middle East, and EKF offers a range of innovative point-of-care solutions. Come to our stand, Z2.J31, to learn more.

MEDLAB is the flagship exhibition and congress of the MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning the Middle East, Asia, East/West Africa, Europe, and the US. This year, the Middle East show is set to welcome over 600 exhibitors and more than 25,000 attendees from 129+ countries.

Point-of-Care Analyzers:

  • Hemo Control
  • DiaSpect Tm
  • HemataStat II™
  • Lactate Scout +
  • Quo-Lab®
  • Quo-Test®
  • Biosen
  • STAT-Site® M BHB
  • Creamatocrit Plus™
  • Pregnancy Tests

Central Laboratory

  • Beta-Hydroxybutyrate LiquiColor® reagent

Staff attending:

  • Steven Wray | EMEA Sales Director
  • Paul Asmar | Regional Sales Manager (Middle East / Central Africa)
  • Rajneesh Mahajan | Regional Sales Manager (India / SAARC)

Event details:

  • MEDLAB Middle East
  • Dubai | 5 – 8 Feb 2018
  • Stand number Z2.J31
  • Venue: Dubai International Convention and Exhibition Centre, Dubai, UAE
  • Web: www.medlabme.com

For specific media enquiries please contact marketing@ekfdiagnostics.com.

For all other product enquiries, sales enquiries, technical support enquiries or anything else regarding our Point-of-Care, Life Sciences, or Central Laboratory products and services please visit our contact page.

Follow EKF

Find out how EKF can help you, contact the team today